EVIO (EVIO) Long-Term Debt: $5.81 Mil (As of Jun. 2020)


What is EVIO Long-Term Debt?

EVIO EVIO -98.00% Long-Term Debt is $5.81 Mil as of Jun. 2020.

EVIO's Long-Term Debt for the quarter that ended in Jun. 2020 was $5.81 Mil.

EVIO's quarterly Long-Term Debt increased from Dec. 2019 ($4.71 Mil) to Mar. 2020 ($5.16 Mil) and increased from Mar. 2020 ($5.16 Mil) to Jun. 2020 ($5.81 Mil).

EVIO's annual Long-Term Debt increased from Sep. 2017 ($1.31 Mil) to Sep. 2018 ($3.76 Mil) and increased from Sep. 2018 ($3.76 Mil) to Sep. 2019 ($3.95 Mil).

EVIO  (OTCPK:EVIO) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

EVIO Long-Term Debt Related Terms

EVIO Long-Term Debt Historical Data

* Premium members only.

The historical data trend for EVIO's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EVIO Long-Term Debt Chart

EVIO Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19
Long-Term Debt
0.00 0.88 1.31 3.76 3.95

EVIO Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.92 3.95 4.71 5.16 5.81
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $5.81 Mil mean?
EVIO (EVIO) has a Long-Term Debt of $5.81 Mil as of Jun. 2020.
Is EVIO's Long-Term Debt too high?
EVIO's current Long-Term Debt is $5.81 Mil.
How does EVIO's Long-Term Debt compare to VCBD and ACCA?
EVIO's Long-Term Debt of $5.81 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. EVIO's current Long-Term Debt is $5.81 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EVIO stock overvalued right now?
EVIO (EVIO) has a current Long-Term Debt of $5.81 Mil. The current Long-Term Debt is $5.81 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For EVIO (EVIO), the current Long-Term Debt is $5.81 Mil as of Jun. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EVIO Business Description

Address 2654 W. Horizon Ridge Drive Parkway, Suite B5-208, Henderson, NV, USA, 89052
EVIO Inc is a Colorado corporation and a diversified holding company. Its subsidiaries provide analytical testing and advisory services to the emerging legalized cannabis industry. The Company performs analytical testing for cannabis and cannabis-derived products, including hemp and CBD products. Its current operations also include pharmaceutical, environmental, stability, and analytical testing, as well as residential and commercial construction and investments, with operations in the United States and Canada.